摘要
目的：探讨良性前列腺增生临床进展的相关因素。方法：回顾性分析我院2010年1月到2012年1月收治的125例良性前列腺增生患者的临床资料。结果：良性前列腺增生临床进展性的危险因素有年龄、血清PSA、前列腺体积、最大尿流率、残余尿量和IPSS评分等。治疗后IPSS评分在25～35约占69.6%明显多于治疗前的41.6%，P<0.05差异有统计学意义。结论：良性前列腺增生是一种慢性进展性疾病，临床进展性的危险因素较多，因此应该监测和控制危险因素，降低BPH发病率，提高老年男性的生活质量。
Abstract
Objective: To investigate the correlation factors of the clinical progression of benign prostatic hyperplasia. Methods: a retrospective analysis of the clinical data of 125 cases of benign prostatic hyperplasia patients in our hospital from 2010 January to 2012 January were analyzed. Results: the risk of clinical progression of benign prostatic hyperplasia factors were age, serum PSA, prostate volume, maximum urine flow rate, residual urine volume and IPSS score. After treatment, IPSS score ranged from 25 to 35 accounted for about 69.6% of the more than 41.6% before treatment, there are significant differences P<0.05. Conclusion: benign prostatic hyperplasia is a chronic progressive disease, more clinical risk factors of progressive, therefore should monitor and control the risk factors, reduce the incidence of BPH, improve the quality of life of older men.
NETL
NSTL
万方数据